InvestSMART

Audalia Resources Limited (ASX: ACP) - Announcements

- Current share price for ACP : $0.022

ASX company news and announcements for Audalia Resources Limited (ACP) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Audalia Resources Limited (ACP) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Audalia Resources Limited (ACP), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Audalia Resources Limited (ACP)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$19 Results of Meeting 30 Nov 2022 4:41PM $0.012 $0.022 risen by 83.33%
$19 Notice of Annual General Meeting/Proxy Form 28 Oct 2022 2:07PM $0.012 $0.022 risen by 83.33%
$19 September 2022 Quarterly Activities Report and Appendix 5B 26 Oct 2022 8:02PM $0.012 $0.022 risen by 83.33%
$19 Update on Funding 26 Oct 2022 7:39PM $0.012 $0.022 risen by 83.33%
$19 Annual Report to shareholders 29 Sep 2022 5:32PM $0.012 $0.022 risen by 83.33%
$19 Corporate Governance Statement and Appendix 4G 29 Sep 2022 5:25PM $0.012 $0.022 risen by 83.33%
$19 Initial Director's Interest Notice 1 Aug 2022 10:29AM $0.013 $0.022 risen by 69.23%
$19 Appointment of Director 1 Aug 2022 10:28AM $0.013 $0.022 risen by 69.23%
$19 June 2022 Quarterly Activities Report and Appendix 5B 29 Jul 2022 3:10PM $0.013 $0.022 risen by 69.23%
$19 Medcalf Project Updated Pre-feasibility Study Results 26 Jul 2022 12:45PM $0.013 $0.022 risen by 69.23%
$19 March 2022 Quarterly Activities Report and Appendix 5B 29 Apr 2022 12:05PM $0.014 $0.022 risen by 57.14%
$19 Bulk sample testwork confirms premium lump ore product 6 Apr 2022 9:28AM $0.013 $0.022 risen by 69.23%
$19 Medcalf Project Updated Mineral Resource estimate 15 Mar 2022 7:28PM $0.011 $0.022 risen by 100%
$19 Interim Financial Report 14 Mar 2022 8:27PM $0.010 $0.022 risen by 120%
$19 Update on Loan Facilities 10 Mar 2022 5:30PM $0.011 $0.022 risen by 100%
$19 December 2021 Quarterly Activities Report and Appendix 5B 31 Jan 2022 6:38PM $0.012 $0.022 risen by 83.33%
$19 Results of Annual General Meeting 30 Nov 2021 6:54PM $0.015 $0.022 risen by 46.67%
$19 Medcalf Project Update 24 Nov 2021 9:21AM $0.015 $0.022 risen by 46.67%
$19 Notice of Annual General Meeting/Proxy Form 29 Oct 2021 1:59PM $0.014 $0.022 risen by 57.14%
$19 September 2021 Quarterly Activities Report and Appendix 5B 29 Oct 2021 10:50AM $0.014 $0.022 risen by 57.14%
$19 Update on Funding 29 Oct 2021 10:47AM $0.014 $0.022 risen by 57.14%
$19 Annual Report to shareholders 30 Sep 2021 6:55PM $0.010 $0.022 risen by 120%
$19 Corporate Governance Statement and Appendix 4G 30 Sep 2021 6:52PM $0.010 $0.022 risen by 120%
$19 June 2021 Quarterly Activities Report and Appendix 5B 30 Jul 2021 5:53PM $0.016 $0.022 risen by 37.50%
$19 Update on Loan Facilities 30 Jun 2021 4:28PM $0.025 $0.022 fallen by 12%

76 - 100 of 269 results

Page 4 of 11

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.